Название продукции:9-Bromo-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine

IUPAC Name:12-bromo-4-[3-methyl-1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-9-oxa-3,6-diazatricyclo[8.4.0.0²,⁶]tetradeca-1(14),2,4,10,12-pentaene

CAS:1282514-63-9
Молекулярная формула:C17H18BrN5O
Чистота:95%+
Номер в каталоге:CM244400
Молекулярная масса:388.27

Упаковочная единица Доступно для заказа Цена ($) Количество
CM244400-250mg in stock ŸŸȋ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:1282514-63-9
Молекулярная формула:C17H18BrN5O
Точка плавления:-
Smiles-код:CC1=NN(C(C)C)C(C2=CN3CCOC4=CC(Br)=CC=C4C3=N2)=N1
Плотность:
Номер в каталоге:CM244400
Молекулярная масса:388.27
Точка кипения:
Номер Mdl:
Хранение:2-8°C

Category Infos

Imidazoles
Imidazole is an important five-membered nitrogen-containing heterocyclic compound. Among the numerous heterocyclic compounds, imidazole and its derivatives are regarded as a unique and multifaceted scaffold material due to their diverse applications in industrial, organic and pharmaceutical chemistry. Imidazoles interact in different ways with many therapeutic targets, enzymes and receptors in biological systems and thus exhibit a wide range of biological activities. In particular, several imidazoles can be used as clinical drugs to treat various types of cancer with high therapeutic efficacy. Furthermore, imidazoles are one of the most critical segments in the field of anti-covid-19 virus drug discovery due to their ability to interact with active targets in living systems.
Imidazole Manufacturer
As a professional imidazole manufacturer, we can guarantee product quality and delivery time.our company has been committed to supply personalized product solutions to customers,pls consult us.
Triazoles
Triazole refers to a heterocyclic compound with the molecular formula C2H3N3, which has a five-membered ring consisting of two carbon atoms and three nitrogen atoms. Neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease already affect many people around the world, and these numbers are increasing rapidly. Treatment for these disorders is often aimed at relieving symptoms and has no cure. Research on new molecules is underway, and heterocyclic compounds have important pharmacological implications. Triazoles and tetrazoles are emerging as new molecules in this field.